1,5-anhydroglucitol monitoring in diabetes: A mass balance perspective

被引:14
|
作者
Nerby, Craig L. [1 ]
Stickle, Douglas F. [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68182 USA
关键词
1,5-anhydroglucitol; Diabetes; ORAL GLUCOSE-TOLERANCE; TERM GLYCEMIC CONTROL; CHRONIC-RENAL-FAILURE; SERUM 1,5-ANHYDROGLUCITOL; PLASMA 1,5-ANHYDRO-D-GLUCITOL; CEREBROSPINAL-FLUID; URINARY-EXCRETION; CLINICAL MARKER; MELLITUS; EXCURSIONS;
D O I
10.1016/j.clinbiochem.2008.08.086
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
1,5-anhydroglucitol (AG) is a nonmetabolizable glucose analogue found in plasma due to ingestion. The normal steady-state concentration can be dramatically decreased by inhibition of tubular reabsorption during periods of hyperglycemia. For this reason, monitoring of AG has been plausibly advocated for detection of periodic glucosuric hyperglycemia. In this review, we examine the influence of variation in factors affecting both steady-state and transient changes in plasma AG. Among normals, the lower and upper limits of the plasma AG reference range vary by a factor of 5. Using a simplified mass balance model (a single compartment model with 3-6x larger-than-plasma volume of distribution), reasonable inter-individual variations of ingestion rate, glomerular filtration rate and fractional post-filtration reabsorption are each able to account for the wide range of normal, steady-state AG concentrations. In monitoring of changes in AG, inter-individual variations in the threshold for glucose excretion, volume of distribution and glomerular filtration rate are all likely to significantly affect correspondence of integral changes in AG to integral glucosuria/ hyperglycemia. This combination of variables, affecting both steady-state and transient changes, is significantly confounding with respect to interpretation of serial plasma AG concentrations. Resolution of information content of AG monitoring is thus largely that of crossing simple characterization of deltas [+,0,-] for changes in AG concentration against the information content of hemoglobin Alc monitoring. Despite this limitation, AG monitoring can in principle provide information about glycemic control in the short term that is not apparent through monitoring of hemoglobin Alc alone. However, whether AG monitoring can lead to improved outcomes in diabetes management remains to be established. (C) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:158 / 167
页数:10
相关论文
共 50 条
  • [31] Glycogenolysis through lyase reaction and 1,5-anhydroglucitol
    Kametani, S
    Akanuma, H
    SEIKAGAKU, 1997, 69 (12): : 1361 - 1372
  • [32] Association of 1,5-anhydroglucitol with Subclinical Cardiovascular Disease
    Liang, Menglu
    McEvoy, John William
    Chen, Yuan
    Sharrett, A. Richey
    Selvin, Elizabeth
    CIRCULATION, 2016, 133
  • [33] 1,5-anhydroglucitol promotes glycogenolysis in Escherichia coli
    Shiga, Y
    Kametani, S
    Kadokura, T
    Akanuma, H
    JOURNAL OF BIOCHEMISTRY, 1999, 125 (01): : 166 - 172
  • [34] 1,5-anhydroglucitol as a circulating biomarker of beta cell loss independently of diabetes onset
    Jimenez-Sanchez, C.
    Mezza, T.
    Di Giuseppe, G.
    Giaccari, A.
    Maechler, P.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S163 - S163
  • [35] Serum 1,5-anhydroglucitol (Glycomark™) levels in children with and without type 1 diabetes mellitus
    Nguyen, Thanh M.
    Rodriguez, Luisa M.
    Mason, Kimberly J.
    Heptulla, Rubina A.
    PEDIATRIC DIABETES, 2007, 8 (04) : 214 - 219
  • [36] PLASMA 1,5-ANHYDROGLUCITOL IN EXPERIMENTAL GALACTOSEMIA IN THE RAT
    PITKANEN, E
    PITKANEN, OM
    EXPERIENTIA, 1990, 46 (01): : 85 - 87
  • [37] Research on Consistency of Mass Spectrometry and Enzymatic Methods for Saliva 1,5-anhydroglucitol Measurement
    Bao, Yuqian
    Jian, Chaohui
    Zhao, Aihua
    Ma, Xiaojing
    Lu, Wei
    Zhu, Wei
    Wang, Yufei
    Zhou, Jian
    DIABETES, 2021, 70
  • [38] REDUCTION OF PLASMA 1,5-ANHYDROGLUCITOL IN DIABETIC-PATIENTS AND EXPERIMENTAL DIABETES IN RATS
    AKANUMA, Y
    YAMANOUCHI, T
    MASHIKO, S
    IWAMOTO, Y
    AKANUMA, H
    DIABETOLOGIA, 1983, 25 (02) : 136 - 136
  • [39] Production of 1,5-anhydroglucitol from 1,5-anhydrofructose in erythroleukemia cells
    Suzuki, M
    Kametani, S
    Uchida, K
    Akanuma, H
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 240 (01): : 23 - 29
  • [40] 1,5-anhydroglucitol stimulates insulin secretion in insulinoma cells
    Inoue, Tae
    Ichiyanagi, Kaoru
    Yamanouchi, Toshikazu
    DIABETES, 2006, 55 : A590 - A590